AI-powered clinical assistant for UK healthcare professionals

What are the current guidelines for referring patients with diabetic retinopathy to ophthalmology for further management?

Answer

Guideline-Aligned (High Confidence)
Generated by iatroX. Developer: Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner).
Last reviewed: 16 August 2025

For patients with diabetic retinopathy, referral to ophthalmology for further management is guided by the findings of the NHS diabetic eye screening programme and specific clinical indicators 2,3.

  • Emergency Ophthalmology Review should be arranged if there is:
    • Sudden loss of vision 2,3.
    • Rubeosis iridis (formation of abnormal blood vessels on the anterior iris) 2,3.
    • Pre-retinal or vitreous haemorrhage 2,3.
    • Retinal detachment 2,3.
  • Urgent Ophthalmology Review should be arranged if there is:
    • Formation of new abnormal vessels on the retina (proliferative diabetic retinopathy) 2,3.
  • Following structured eye screening, a patient may be referred to an ophthalmologist, have an earlier review, or continue with routine annual review, depending on the findings 2,3.
  • When starting a diabetes treatment that is likely to result in a rapid, substantial drop in the person's HbA1c, the person's ophthalmologist should be notified so they can assess the eyes before treatment begins and check for changes afterwards 1.
  • Hospital eye services should monitor disease progression in people with moderate, severe, or very severe non-proliferative retinopathy who are not currently having treatment and have not previously had treatment 1. This includes considering reviews every 6 to 12 months for moderate non-proliferative diabetic retinopathy, and every 3 to 6 months for severe or very severe non-proliferative retinopathy 1.

Related Questions

Finding similar questions...

This content was generated by iatroX. Always verify information and use clinical judgment.